Clinical trials
HIV clinical trials
Below are recruiting hiv clinical trials, each written for real people, not researchers. We’re tracking 611 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04663152Recruiting
Study support to help you stay on treatment
This study tests integrated support that includes counseling, help with following your treatment plan, and research activities to improve treatment adherence. You may be a good match if you live in Miami-Dade and meet the viral load requirement.
Miami, FloridaAges 18 years+ - NCT05377463Recruiting
Behavior coaching to help keep HIV virus levels controlled
This study tests a counseling program (bio-behavioral intervention) designed to help people with HIV keep their virus levels under control over time. It may be especially relevant if your current HIV treatment has been hard to stick with or you haven’t had recent viral load checks.
Ciudad Juárez, ChihuahuaAges 18 years+ - NCT03731559RecruitingPhase 2
HIV treatment with dolutegravir plus rifampicin during TB care
This Phase 2 study tests how well and how safely an HIV medicine (dolutegravir) works when given with rifampicin, a common anti-TB medicine, for people starting HIV treatment during TB treatment. It also studies drug levels in the body to help confirm dosing and safety while treating both infections.
Bangkok, BangkokAges 18 years+ - NCT03174977RecruitingEarly Phase 1
How HIV medicine moves through the body on MRI scans
This early study measures how raltegravir (an HIV medicine) spreads in the body using a special scan called PET/MR. It may help doctors better understand how to deliver and monitor HIV treatment, even though it focuses on measuring drug behavior rather than curing HIV.
San Francisco, CaliforniaAges 18 years+ - NCT02437981Enrolling by invitation
PrEP for HIV prevention in high-risk adults in Thailand
This trial checks how well PrEP pills (TDF/FTC) prevent HIV in people who are at high risk and are HIV-negative. It may help you understand whether PrEP is a good prevention option for your situation.
Bangkok, PathumwanAges 18 years+ - NCT01336855Recruiting
Provide blood for studies comparing HIV groups
This study collects blood to help researchers run multiple projects, including comparing people who are HIV-negative with people who have HIV. It may help advance knowledge that could improve future testing or treatments.
San Francisco, CaliforniaAges 18 years+ - NCT03893188Recruiting
SwissPrEPared program study for HIV-negative teens and adults
This study looks at people who join the SwissPrEPared program and who are HIV-negative. It tests how well the program’s steps can be followed and how participants do while enrolled.
Aarau, Canton of AargauAges 16–120 - NCT04158895Recruiting
HIV care records study to improve HIV treatment in Malawi
This study gathers information from people receiving HIV care in Malawi to better understand and improve HIV treatment. You may be included if you are an adult or older and you are currently accessing HIV care during the study’s time period.
LilongweAges 15 years+ - NCT04149782Recruiting
HIV care records review in South Africa
This study gathers and reviews existing records from people receiving care for HIV in South Africa. It aims to better understand how HIV treatment is working in real-world settings and for different types of risk groups.
JohannesburgAges 15 years+ - NCT02761200Recruiting
Study pause of HIV treatment in people already enrolled
This study looks at what happens when HIV treatment (ART) is intentionally paused in people who are already enrolled in a specific research study (RV254) and recently joined a protocol that included an earlier treatment pause. It may help researchers understand safety and how to manage treatment changes, but it has strict participation and consent requirements.
Bangkok, BangkokAges 18 years+ - NCT06507059RecruitingPhase 3
Injectable HIV treatment trial for people with unsuppressed virus
This trial tests if switching to a long-acting injectable medication can help people with HIV who have trouble keeping their virus suppressed with daily pills. You would receive shots in the buttocks every few months instead of taking pills every day.
KeelungAges 18 years+ - NCT06206564RecruitingPhase 2
Artesunate ointment for anal precancer in HIV-negative adults
This trial tests an artesunate ointment to treat high-grade anal precancer (HSIL) in people who do not have HIV. The goal is to see if the ointment can clear the abnormal cells caused by HPV.
Chicago, IllinoisAges 18 years+ - NCT06162897Recruiting
Case management for HIV or PrEP care support
This study tests whether pairing a case manager with people living with HIV or taking PrEP can help them stay in care and address financial or food problems.
Chicago, IllinoisAges 18 years+ - NCT07308782RecruitingPhase 2
Testing a new HIV treatment in people not yet on therapy
This trial is testing an experimental HIV pill called CL-197. It's for people with HIV who have never taken any HIV medicines before. The study lasts about 2 weeks and aims to see how the drug works in the body.
BeijingAges 18–60 - NCT07497594Recruiting
Twice-yearly shots to prevent HIV
This trial tests a new HIV prevention medicine called lenacapavir, given as a shot every six months. It's for young people at risk of HIV who haven't used PrEP before or have had gaps in their PrEP use.
Manaus, AmazonasAges 16–30 - NCT05352061Enrolling by invitation
HIV support program for people with mental health and life challenges
This study looks at how an HIV treatment and prevention program can be improved for people who have HIV plus psychosocial challenges, especially when HIV is not well controlled. You may be able to join if your HIV is recent and higher than target, and you fit one of the specific participant groups.
Miami, FloridaAges 18 years+ - NCT06678022Recruiting
Using medical drones to deliver HIV treatment in Kalangala
This study tests whether medical drones can safely deliver HIV medications and lab samples in remote areas. If successful, it could help people living with HIV get their medicine faster and more reliably.
Kalangala, SseseAges 15 years+ - NCT07349758RecruitingPhase 1
Single dose of two PrEP tablets in healthy volunteers
This study tests how taking two tablets of a PrEP medication (F/TAF) at once affects healthy volunteers. It helps us understand the safety and how the body processes the drug.
Baltimore, MarylandAges 18 years+ - NCT07052409Enrolling by invitation
Protecting HIV-exposed infants from severe infections
This trial studies ways to protect babies who were exposed to HIV before birth but are not infected themselves. It aims to find better interventions to prevent severe infections in these infants.
JohannesburgAges 6 months–45 years - NCT07102745Recruiting
Home support after HIV hospital stay
This trial tests if structured home care and nutritional support can help people with HIV recover and stay healthy after leaving the hospital. If you live in the Matlosana area and were recently admitted to Tshepong Hospital, you may be able to join.
Klerksdorp, North WestAges 18 years+ - NCT06741306Recruiting
Long-term health study of young gay men who use drugs during sex
This study follows young men who have sex with men and use drugs during sex (chemsex) to understand their health and behaviors. It aims to provide better care and support.
Bangkok, BangkapiAges 16–35 - NCT05804461Recruiting
PrEP support study for Latino gay and bisexual men in Puerto Rico
This study tests ways to help Latino men who have sex with men use PrEP, a medicine that helps prevent HIV. You may be invited if you are HIV-negative (or your status is unknown), are not currently on PrEP, and can read and write Spanish.
San JuanAges 21–99 - NCT05985642Recruiting
HIV treatment interruption study for long-term participants
This study looks at people with HIV who have already taken a break from their HIV medications (called an analytic treatment interruption, or ATI) as part of another study. It aims to understand how well the body can control the virus during longer breaks from treatment, up to 96 weeks.
San Francisco, CaliforniaAges 18 years+ - NCT06444360Recruiting
Program to reduce stimulant use and risky sex in young adults
This study tests a program to help sexually active young adults reduce stimulant use and risky sexual behavior. It involves online coaching sessions, and you can join from home if you have a private space and video chat access.
Los Angeles, CaliforniaAges 16–24
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hiv?
- Yes. Clin2 currently lists 611 recruiting hiv studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hiv trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hiv trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.